Millennium Management’s Genocea Biosciences, Inc. GNCA Stock Holding History

Millennium Management’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-420,800	Closed	-$526K	–	7915
2022 Q1	$526K	Buy	+420,800	New	+$458K	﹤0.01%	5091

Other funds holding GNCA

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

AICPI

ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Millennium Management's GNCA Position: Q2 2022 in Review

Millennium Management sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2022, closing a stake of 215,002 shares — an estimated $269K sold.

Millennium Management first reported a position in GNCA in Q1 2015 and held it in 25 quarters. The position peaked at $6.11M in Q2 2015. 5 funds tracked by Wall St. Rank hold GNCA as of Q2 2022.

Millennium Management reported no remaining Genocea Biosciences, Inc. position as of Q2 2022 after selling out during the quarter.
Millennium Management sold 215,002 Genocea Biosciences, Inc. shares in Q2 2022, an estimated $269K.
Millennium Management first reported a position in Genocea Biosciences, Inc. in Q1 2015 and held it in 25 quarters.
Millennium Management's Genocea Biosciences, Inc. position peaked at $6.11M in Q2 2015.
5 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2022.

Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.